99 results found.
        
NuVasive Reports Preliminary 4Q16 and 2016 Revenue
NuVasive announced preliminary unaudited 2016 sales of ~US $956.0MM, +17.9% from 2015, with 4Q16 revenue of ~$265.0MM...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
NuVasive Reports 3Q16 Revenue
NuVasive reported 3Q16 revenue of US $239.6MM, +19.5% from 3Q15. (U.S. $208.3MM, +18.1%; ex-U.S. $31.4MM, +29.8%)...
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
NuVasive Reports 2Q16 Revenue
NuVasive reported 2Q16 revenue of US $236.2MM, +16.4% from 2Q15. (U.S. $200.5MM, +12.7%; ex-U.S. $35.6MM, +43.6%)...
NuVasive Reports 1Q16 Revenue
NuVasive reported 1Q16 revenue of US $215.1MM, +11.8% from 1Q15. (U.S. $186.4MM, +11.1%; ex-U.S. $28.7MM, +16.7%)...
Company Revenue 2015: NuVasive
Download the March issue of ORTHOKNOW for a graphical presentation of 2015 company performance. 2015: $811.1MM, +8.2%
NuVasive Posts 4Q15/2015 Revenue
NuVasive (NUVA) posted 4Q15 revenue of US $215.3MM, +6.8% vs. 4Q14, and 2015 revenue of $811.1MM, +8.2% from 2...
NuVasive Reports Preliminary 4Q15 and 2015 Revenue
NuVasive announced preliminary unaudited 2015 revenue of ~US $811MM, +8% from 2014, and 4Q15 revenue of ...
NuVasive 3Q15 Revenue Up 7.8% CC vs. 3Q14
NuVasive posted 3Q15 revenue of US $200.5MM, +5.6% as reported and +7.8% in constant currency, and YTD 2015 re...
BARE BONES® - July 28, 2015
NuVasive announced 2Q15 revenue of US $202.9MM, +8.5% from 2Q14. Growth reflects constant currency. (NuVasive, Inc., 7/28/15)
BARE BONES® - May 4, 2015
NuVasive announced 1Q15 revenue of US $192.4MM, +10% from 1Q14. Growth reflects constant currency. (NuVasive, Inc., 5/4/15)
BARE BONES® - February 25, 2015
NuVasive announced 4Q14 revenue of US $204.3MM, +7.1% vs. 4Q13, and 2014 revenue of $762.4MM, +11.6% vs. 2013. (
2014 Revenue: NuVasive
4Q14 revenue: $204.3MM, +7% (Ex-U.S. +36%; U.S. Lumbar +4%, U.S. Cervical +5%) Biologics +9% Monitoring Service -4% Precept posterior fixation surpassed $100MM in cumulative sales since launch   2014 reve...
BARE BONES® - January 12, 2015
NuVasive announced preliminary 4Q14 revenue of ~US $203MM and preliminary 2014 revenue of ~$761MM, >12% constant currency growth vs. 2013. (
BARE BONES® - October 30, 2014
NuVasive announced 3Q14 revenue of US $189.9MM, +12.3% from 3Q13. (NuVasive, Inc., 10/30/14)
3Q14 Revenue: NuVasive
$189.9MM, +12% (ex-U.S. +45%) U.S. Lumbar +8% U.S. Biologics +13% U.S. Cervical -2% U.S. IOM Service +14%   Price pressure less than -2%, consistent with previous quarters Mo...
BARE BONES® - July 29, 2014
NuVasive announced 2Q14 revenue of US $190.7MM, +15.1% from 2Q13. (NuVasive, Inc., 7/29/14)
2Q14 Revenue: NuVasive
$190.7MM, +15% (U.S. $167.0MM, +10%; ex-U.S. $23.6MM, +56%) Spine Surgery $147.3MM, +14% Biologics $32.8MM, +18% Monitoring Service $10.5MM, +15%   U.S. growth: Lumbar +10%, Biologics +18%, Cervical -1%, ...
BARE BONES® - April 29, 2014
NuVasive announced 1Q14 revenue of US $177.5MM, +11.3% from 1Q13. (NuVasive, Inc., 4/29/14...
1Q14 Revenue: NuVasive
$177.5MM, +11% (Ex-U.S. +34%) U.S. Lumbar +8% U.S. Biologics +9% U.S. Cervical +9% U.S. Monitoring +11%   International driven by strong growth in Europe, Asia Pacific, offset by economy in...
BARE BONES® - March 3, 2014
NuVasive reported 4Q13 revenue of US $190.8MM, +15.1% from 4Q12, and 2013 revenue of $685.2MM, +10.5% from 2012. (
4Q13/2013 Revenue: NuVasive
4Q13 revenue: $190.8MM, +15% (Ex-U.S. +40 U.S. Lumbar +12% U.S. Cervical +17% U.S. Biologics+12% Impulse Monitoring +15%   2013 revenue: $685.2MM, +11% (Ex-U.S. >$70MM, +30%+) ...
BARE BONES® - January 15, 2014
NuVasive announced preliminary 4Q13 revenue of ~US $189MM, +14% from 4Q12, and preliminary 2013 revenue of ~$683MM, >10% growth vs. 2012. (
BARE BONES® - October 29, 2013
NuVasive announced 3Q13 revenue of US $169.2MM, +14% from 3Q12. (NuVasive, Inc., 10/29/13)
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group